MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Bio Blast Pharma Ltd Company Profile (NASDAQ:ORPN)

Consensus Ratings for Bio Blast Pharma Ltd (NASDAQ:ORPN) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $28.50 (411.67% upside)

Analysts' Ratings History for Bio Blast Pharma Ltd (NASDAQ:ORPN)
Show:
DateFirmActionRatingPrice TargetActions
8/23/2015Roth CapitalReiterated RatingBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015Roth CapitalBoost Price TargetBuy$18.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2015Roth CapitalReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015Roth CapitalBoost Price TargetBuy$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2014OppenheimerReiterated RatingOutperform$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Roth CapitalInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014OppenheimerInitiated CoverageOutperform$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/4/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha